Differentially Methylated Regions in Desmoid-Type Fibromatosis: A Comparison Between CTNNB1 S45F and T41A Tumors-Reference-Cited by-同舟云学术

Differentially Methylated Regions in Desmoid-Type Fibromatosis: A Comparison Between CTNNB1 S45F and T41A Tumors

Published:2020-10-29 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Timbergen Milea J. M.,Boers Ruben,Vriends Anne L. M.,Boers Joachim,van IJcken Wilfred F. J.,Lavrijsen Marla,Grünhagen Dirk J.,Verhoef Cornelis,Sleijfer Stefan,Smits Ron,Gribnau Joost,Wiemer Erik A. C.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference41 articles.

1. Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells;Wu;Cancer Res,2010

2. Nuclear beta-catenin in mesenchymal tumors;Ng;Mod Pathol,2005

3. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis;Crago;Genes Chromosomes Cancer,2015

4. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors;Lazar;Am J Pathol,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FOXK2 targeting by the SCF-E3 ligase subunit FBXO24 for ubiquitin mediated degradation modulates mitochondrial respiration;Journal of Biological Chemistry;2024-06

2. Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response;Human Genomics;2023-04-25

3. Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis;Human Cell;2023-01-11

4. Aggressive fibromatosis in a child: a diagnostic challenge;Pathology;2022-12

5. FOXK2 transcription factor and its roles in tumorigenesis (Review);Oncology Letters;2022-11-03